Medibank Private (MPL.AX) Akcie Kurz
Medibank Private Kurz
Tržby rostly o 5,8 % ročně za posledních 19 let na 9,33 Mld. AUD. Zisk na akcii rostl o 8,1 % ročně za posledních 13 let. čistá marže společnosti Medibank Private je nyní 6,8 %, nahoru z 5,6 % před několika lety. Medibank Private aktuálně nabízí dividendový výnos kolem 2,50 %. Výplatní poměr je kolem 129 % zisku. Dividenda rostla o 4,2 % ročně za posledních 11 let. Medián cílové ceny analytiků je 5,00 AUD, tedy nad aktuální cenu o 5,4 %. Z 14 analytiků jich 5 doporučuje nákup — celkový konsenzus je Držet.
Cena akcie Medibank Private
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Medibank Private a analýza akcií
Nejčastější otázky týkající se akcie Medibank Private
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analytici aktuálně stanovují průměrnou cílovou cenu 5,22 AUD pro akcii Medibank Private (medián: 5,00 AUD), tedy +10,0 % vůči poslední ceně. Konsensus vychází z 14 hodnocení analytiků.
14 analytiků aktuálně hodnotí akcii Medibank Private: 5 doporučuje koupit, 9 držet a 0 prodat.
Při aktuálním kurzu se akcie Medibank Private obchoduje za 2,93 EUR (4,74 AUD).
Akcie Medibank Private (MPL.AX) je kótována na 5 burzách, mimo jiné: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
Tržby za Medibank Private činí 9,33 Mld. AUD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk za Medibank Private činí 638,70 Mil. AUD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Medibank Private je aktuálně 20,44. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Medibank Private.
Poměr ceny k tržbám (P/S) Medibank Private je aktuálně 1,40. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Medibank Private.
Score kvality pro Medibank Private je 5/10.
ISIN Medibank Private je AU000000MPL3. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Medibank Private je A12D1W. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Medibank Private je MPL.AX. Symbol tickeru se používá k obchodování akcií Medibank Private na burze.
Medibank Private akcie
Medibank Private Peer Group
Medibank Private Ticker
Medibank Private FIGI
Všechny fundamentální údaje o Medibank Private v podrobné analýze
Naše analýzy akcií společnosti Medibank Private zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Medibank Private. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: